SCHEMBL14694747

SCHEMBL14694747

CC(C)(c1ccc(OC[C@H](O)CF)cc1)c1ccc(OC[C@H](O)CCl)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 2/20 0.76
▸ HTT P42858 3/20 0.61
▸ HIF1A Q16665 1/20 0.61
▸ KMT2A Q03164 4/20 0.48
▸ MAPT P10636 5/20 0.45
▸ GAA P10253 1/20 0.45
▸ KDM4E B2RXH2 4/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ LMNA P02545 3/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ MITF O75030 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ CYP2D6 P10635 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CYP1A2 P05177 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14695376 1.00 AR (0.76) ARHTTHIF1AKMT2AMAPT
SCHEMBL14695206 1.00 AR (0.76) ARHTTHIF1AKMT2AMAPT
SCHEMBL14694748 1.00 AR (0.76) ARHTTHIF1AKMT2AMAPT
SCHEMBL14695443 1.00 AR (0.76) ARHTTHIF1AKMT2AMAPT
SCHEMBL12267352 0.92 HIF1A (0.65) ARHTTHIF1AKMT2AMAPT
SCHEMBL6131219 0.92 AR (0.88) ARHTTHIF1AKMT2AMAPT
SCHEMBL12515785 0.92 AR (0.88) ARHTTHIF1AKMT2AMAPT
SCHEMBL16387676 0.92 AR (0.65) ARHTTHIF1AKMT2AMAPT
SCHEMBL16281213 0.91 AR (0.85) ARHTTHIF1AKMT2AMAPT
SCHEMBL14707380 0.90 AR (0.63) ARHTTHIF1AKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2744773-B1 FLUORINATED BISPHENOL ETHER COMPOUNDS AND METHODS FOR THEIR USE BRITISH COLUMBIA CANCER AGENCY (CA) 2016-11-02 — — EP disclosed
WO-2013028572-A1 FLUORINATED BISPHENOL ETHER COMPOUNDS AND METHODS FOR THEIR USE BRITISH COLUMBIA CANCER AGENCY BRANCH (CA) 2013-02-28 — — WO disclosed
US-20130045204-A1 FLUORINATED BISPHENOL ETHER COMPOUNDS AND METHODS FOR THEIR USE THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-02-21 — — US disclosed
US-20130045204-A1 FLUORINATED BISPHENOL ETHER COMPOUNDS AND METHODS FOR THEIR USE THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-02-21 — — US disclosed
US-20130045204-A1 FLUORINATED BISPHENOL ETHER COMPOUNDS AND METHODS FOR THEIR USE THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-02-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130045204-A1 FLUORINATED BISPHENOL ETHER COMPOUNDS AND METHODS FOR THEIR USE AR, ESRRA, ESR1 AR 1/4885HTT 3985/4885HIF1A 3869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback